CYP2C19 and neuroblastoma: Although, neuroblastoma considered to be the most prevalent extracranial solid tumour malignancy in childhood1,2, cyclophosphamide-induced toxicity related to the patients’ CYP2B6 and CYP2C19 status has not been extensively investigated in patients with neuroblastoma.